Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Ungrouped

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06651931Completed

CT Indices Analysis in ICU Pneumonia Patients With Acute Respiratory Failure (CT:Computed Tomography, ICU: Intensive Care Unit)

NCT06299865Unknown

Comparison of Detection Rates Between Two Commonly Used Bone Density Measurement Methods

NCT04953247Completed

Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19

Showing all 3 trials

Research Network

Common Treatments

  • Ungrouped1

Active Sponsors

  • Kocaeli University1
  • Guowei Tu1
  • Xiaoqian Zhang1

Related Conditions

  • Dual Energy Xray Absorptiometry1
  • Diagnosis1
  • Osteoporosis1
  • Acute Respiratory Failure1
  • Covid19 Pneumonia1

Activity Timeline